Drug Repurposing and Computational Drug Discovery for Viral Infections and COVID-19

M. V. Manohar; Amogha G. Paladhi; Bhoomika Inamdar; Kotthapalli Prashanth; Sugumari Vallinayagam; Mithun Rudrapal

doi:10.1007/978-981-99-1316-9_15

ScienceGate Book Chapters

BOOK-CHAPTER

Drug Repurposing and Computational Drug Discovery for Viral Infections and COVID-19

M. V. Manohar Amogha G. Paladhi Bhoomika Inamdar Kotthapalli Prashanth Sugumari Vallinayagam Mithun Rudrapal

Year: 2023 Interdisciplinary biotechnological advances Pages: 355-366

DOI: 10.1007/978-981-99-1316-9_15

Get Full-Text PDF Get Analytical Report

Keywords:

Drug repositioning Repurposing Drug Drug discovery Favipiravir Medicine Approved drug Antiviral drug Pharmacology Ribavirin Disease Intensive care medicine Coronavirus disease 2019 (COVID-19) Virus Virology Bioinformatics Infectious disease (medical specialty) Biology Internal medicine

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.15

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Computational Drug Discovery Methods

Physical Sciences → Computer Science → Computational Theory and Mathematics

SARS-CoV-2 and COVID-19 Research

Health Sciences → Medicine → Infectious Diseases

COVID-19 Clinical Research Studies

Health Sciences → Medicine → Infectious Diseases

Drug Repurposing and Computational Drug Discovery for Viral Infections and COVID-19

Metrics

Topics

Related Documents

Drug Repurposing and Computational Drug Discovery for Viral Infections and Coronavirus Disease-2019 (COVID-19)

Drug Repurposing and Computational Drug Discovery

Computational Drug Discovery for Emerging Viral Infections

Recent omics-based computational methods for COVID-19 drug discovery and repurposing

Recent omics-based computational methods for COVID-19 drug discovery and repurposing